NYSE:ELMD Electromed (ELMD) Stock Price, News & Analysis $37.48 +0.35 (+0.93%) As of 02:58 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Electromed Stock (NYSE:ELMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Electromed alerts:Sign Up Key Stats Today's Range$37.19▼$38.9250-Day Range$23.29▼$39.2952-Week Range$17.73▼$40.00Volume43,796 shsAverage Volume60,809 shsMarket Capitalization$310.38 millionP/E Ratio50.01Dividend YieldN/APrice Target$37.50Consensus RatingBuy Company Overview Electromed Inc. (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients. The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components. Electromed produces private-label and branded items that meet or exceed industry quality standards, supplying home healthcare providers, sleep clinics and respiratory therapists. Its integrated manufacturing processes—from material sourcing to final assembly—aim to ensure product consistency, quick turnaround times and cost efficiencies for its customers. Founded in 2003 and headquartered in Jacksonville, Florida, Electromed operates manufacturing and distribution facilities within the United States and maintains a growing international customer base. The company’s vertically integrated operations and emphasis on research and development support ongoing product innovation and regulatory compliance. Electromed’s management team draws on decades of experience in the medical device sector to guide strategic growth and expand market reach.AI Generated. May Contain Errors. Read More Electromed Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreELMD MarketRank™: Electromed scored higher than 18% of companies evaluated by MarketBeat, and ranked 792nd out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingBuy Consensus RatingElectromed has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 1 strong buy rating, 3 buy ratings, no hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Electromed is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageElectromed has only been the subject of 2 research reports in the past 90 days.Read more about Electromed's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Electromed is 50.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Electromed is 50.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.00.Price to Book Value per Share RatioElectromed has a P/B Ratio of 7.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ELMD. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldElectromed does not currently pay a dividend.Dividend GrowthElectromed does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.31 News SentimentElectromed has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Electromed this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for ELMD on MarketBeat in the last 30 days. This is a decrease of -73% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Electromed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,202,216.00 in company stock.Percentage Held by Insiders10.50% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions40.82% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Electromed's insider trading history. Receive ELMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ELMD Stock News HeadlinesElectromed: Strong Margins, Strong Growth, Large RunwayJune 13 at 10:01 AM | seekingalpha.comJames Cunniff Sells 9,700 Shares of Electromed (NYSE:ELMD) StockJune 10, 2026 | insidertrades.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.June 15 at 1:00 AM | Porter & Company (Ad)Electromed (NYSE:ELMD) CFO Sells $428,966.35 in StockJune 9, 2026 | insidertrades.comElectromed (NYSE:ELMD) Director Sells $1,419,200.00 in StockMay 20, 2026 | insidertrades.comElectromed Inc (ELMD) Q3 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ...May 13, 2026 | finance.yahoo.comElectromed, Inc. (ELMD) Q3 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comElectromed Reports Record Q3 Revenue and Profit GrowthMay 12, 2026 | tipranks.comSee More Headlines ELMD Stock Analysis - Frequently Asked Questions How have ELMD shares performed this year? Electromed's stock was trading at $29.12 on January 1st, 2026. Since then, ELMD shares have increased by 31.0% and is now trading at $38.1590. How were Electromed's earnings last quarter? Electromed, Inc. (NYSE:ELMD) released its quarterly earnings data on Tuesday, November, 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million for the quarter. Electromed had a trailing twelve-month return on equity of 15.71% and a net margin of 11.34%. How will Electromed's stock buyback program work? Electromed's Board of Directors authorized a share buyback plan on Monday, March 10th 2025, which authorizes the company to repurchase $5,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 2.4% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its shares are undervalued. When did Electromed IPO? Electromed (ELMD) raised $10 million in an initial public offering (IPO) on the week of October 3rd 2011. The company issued 2,000,000 shares at $4.00-$6.00 per share. Who are Electromed's major shareholders? Electromed's top institutional investors include Punch & Associates Investment Management Inc. (2.71%), Dimensional Fund Advisors LP (2.15%), Hunter Associates Investment Management LLC (1.82%) and Renaissance Technologies LLC (1.50%). Insiders that own company stock include James L Cunniff, Kathleen Skarvan, Bradley M Nagel and Andrew Summers. View institutional ownership trends. How do I buy shares of Electromed? Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Electromed own? Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings11/12/2024Today6/15/2026Fiscal Year End6/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 ELMD's financial health is in the Green zone, according to TradeSmith. ELMD has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNYSE:ELMD CIK1488917 Websmartvest.com Phone(952) 758-9299Fax866-758-5077Employees160Year Founded1992Price Target and Rating Average Price Target for Electromed$37.50 High Price Target$40.00 Low Price Target$36.00 Potential Upside/Downside-0.3%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$1.17 Trailing P/E Ratio50.17 Forward P/E RatioN/A P/E GrowthN/ANet Income$5.15 million Net Margins11.34% Pretax Margin15.57% Return on Equity15.71% Return on Assets13.37% Debt Debt-to-Equity RatioN/A Current Ratio5.10 Quick Ratio4.74 Sales & Book Value Annual Sales$71.75 million Price / Sales4.34 Cash Flow$0.91 per share Price / Cash Flow41.36 Book Value$5.10 per share Price / Book7.38Miscellaneous Outstanding Shares8,280,000Free Float7,359,000Market Cap$311.58 million OptionableOptionable Beta0.53 Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:ELMD) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
